Eterna Therapeutics Inc.

Historical 13F Holders

Symbol: ERNA
CUSIP: 114082209
All holders as of: Q1 2025
Type: Equity
Class: COM NEW

Reported Value, Excluding Options

Total Shares Held, Excluding Options

Total Filers

13D/G Filers

Each filer's latest filing for 114082209 since 12/18/2024, largest first.

Filer	% of Class	Shares	Form	Filed
Charles Cherington 13D/A	37.9%	41,690,775	13D/A	6/11/2025 Event 6/9/2025
Freebird Partners LP 13G/A	9.9%	6,211,530	13G/A	5/14/2025 Event 3/31/2025
Freebird Partners LP	9.9%	6,211,530
Freebird Investments LLC	9.9%	6,211,530
Curtis Huff	9.9%	6,211,530
John D. Halpern 13G/A	9.6%	5,971,830	13G/A	5/15/2025 Event 3/31/2025
John D. Halpern	9.6%	5,971,830
Katherine H. Halpern	9.6%	5,971,830
Iaf, LLC 13G/A	5.2%	3,255,421	13G/A	5/14/2025 Event 3/31/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Shameek Konar 13G Amended under CUSIP 114082407 on 5/13/2026	5.5%	3,435,304	13G	5/15/2025 Event 3/31/2025
Shameek Konar	5.5%	3,435,304
Victoria Konar	5.5%	3,435,304
Regolith Capital Investments LP	5.4%	3,343,192
Nicholas Jason Singer 13G/A	4.9%	2,565,001	13G/A	2/14/2025 Event 12/31/2024
Nicholas Jason Singer	4.9%	2,565,001
Purchase Capital LLC	2.0%	1,000,001

13F Holders by Quarter

Period	Filers	Shares, Excl. Options	Value, Excl. Options	Options Value
2025 Q1	30	1.49 M	$264k	$0
2024 Q4	27	995 k	$292k	$0
2024 Q3	23	712 k	$747k	$0
2024 Q2	21	390 k	$712k	$0
2024 Q1	24	409 k	$981k	$0
2023 Q4	21	355 k	$637k	$0
2023 Q3	23	331 k	$728k	$0
2023 Q2	21	333 k	$750k	$0
2023 Q1	22	332 k	$1.14M	$0
2022 Q4	21	330 k	$1.19M	$0